Download presentation
Presentation is loading. Please wait.
Published byJonathan Romero Modified over 5 years ago
1
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Chapter 26 Copyright © 2016 F.A. Davis Company
2
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Copyright © 2016 F.A. Davis Company
3
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Copyright © 2016 F.A. Davis Company
4
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Copyright © 2016 F.A. Davis Company
5
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Follicular phase is characterized by increased pituitary gland production of FSH. FSH stimulates estrogen secretion by the ovary and initiates development of an ovum that rises to the surface at a region called the Graafian follicle. Proliferation of the uterine lining Day 1 to 14 Copyright © 2016 F.A. Davis Company
6
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell At a peak level of FSH, the pituitary releases LH, resulting in ovulation, which is defined as the release of an ovum from the ovary. The ovum travels from the ovary to the uterus via the fallopian tube. The ovarian germination region is called the corpus luteum. Copyright © 2016 F.A. Davis Company
7
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Corpus luteum progesterone From day 14 through 28 Secretory phase of uterine lining Corpus luteum degenerates if no pregnancy; corpus luteum continually supplies progesterone if pregnancy. Copyright © 2016 F.A. Davis Company
8
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Copyright © 2016 F.A. Davis Company
9
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell The permanent cessation of menstrual cycles because of normal, physiological degeneration of the ovaries and the decline of estrogen levels over 12 months. In the time frame before menopause, called perimenopause, there is gradual decline in hormone production; this decline can last several years and cause physiological changes that include erratic menses, atrophic vaginitis, and vasomotor instability. Estrogen sharply declines during this time, which causes feedback to the pituitary gland. Copyright © 2016 F.A. Davis Company
10
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Estrogen sharply declines during this time, which causes feedback to the pituitary gland. The pituitary gland, in an attempt to increase ovarian secretion of estrogen, secretes high levels of FSH. However, with the degeneration of the ovaries, estrogen is no longer secreted. The stage of perimenopause can be confirmed by an elevated FSH level. Copyright © 2016 F.A. Davis Company
11
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Infection of the endometrium, which is the uterine lining, can occur in association with instrumentation of the uterus, abortion, childbirth, pelvic inflammatory disease (PID), or an implanted intrauterine device (IUD). Microorganisms such as Gonococcus, Chlamydia trachomatis, Enterococcus, and several strains of anaerobic bacteria are the most common causes of endometritis. Copyright © 2016 F.A. Davis Company
12
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Copyright © 2016 F.A. Davis Company
13
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Endometriosis is the growth of endometrial tissue outside the uterus. The most common sites are the ovaries, uterine ligaments, rectovaginal septum, pelvic peritoneum, umbilicus, vagina, vulva, and appendix. Endometrial tissue in these sites bleed monthly. Endometriosis commonly causes infertility, dysmenorrhea, and pelvic pain. Copyright © 2016 F.A. Davis Company
14
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Pelvic pain in the reproductive years is a common presentation of endometriosis. There are no physical examination findings. Definitive diagnosis requires laparoscopy. Copyright © 2016 F.A. Davis Company
15
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Copyright © 2016 F.A. Davis Company
16
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell A mass that protrudes into the endometrial cavity They are usually benign, but coexistence of atypical endometrial hyperplasia or adenocarcinoma is common. Tamoxifen is a common cause. Copyright © 2016 F.A. Davis Company
17
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Copyright © 2016 F.A. Davis Company
18
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Commonly referred to as fibroid tumors Benign tumors Sharply circumscribed firm growths that are most commonly found in the myometrium Cause abnormal vaginal bleeding, bladder compression, dysmenorrhea, back pain, or infertility Excessive menstrual bleeding can occur that causes anemia. Copyright © 2016 F.A. Davis Company
19
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Abnormal uterine bleeding that is caused by a disturbance of the menstrual cycle. The diagnosis of DUB can indicate an excessive loss of blood from the uterus or it can indicate lack of normal menstruation at cyclical periods. It can occur in anovulatory or ovulatory menstrual cycles. Copyright © 2016 F.A. Davis Company
20
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Anovulatory cycles are the most common cause of DUB. Anovulatory DUB can be demonstrated as a condition of missed periods, prolonged intervals between menses, more frequent periods than normal, or excessive menstrual blood loss. Copyright © 2016 F.A. Davis Company
21
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell A thick layer of endometrium accumulates with no stimulus for menstruation; consequently, amenorrhea occurs. Eventually, the excessive endometrial layer does break down and the woman experiences an irregular menstrual cycle and flow irregularities such as menorrhagia, metrorrhagia, menometrorrhagia, intermenstrual spotting, and oligomenorrhea. Copyright © 2016 F.A. Davis Company
22
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell In women with ovulatory DUB, there is an increased rate of blood loss resulting from endometrial vascular vasodilatation, decreased vascular tone, and excessive prostaglandins. Women suffer heavy menstrual blood loss, up to three times normal. Large menstrual blood loss often causes anemia. Copyright © 2016 F.A. Davis Company
23
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Copyright © 2016 F.A. Davis Company
24
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Normally for ovulation to occur, the ovary develops a follicle (Graafian follicle) that matures on the ovary surface and contains an ovum. The Graafian follicle containing the ovum normally ruptures and ejects the ovum in a process known as ovulation. When the follicle does not eject the ovum, this is called a follicular cyst. Copyright © 2016 F.A. Davis Company
25
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell PCOS is the most common endocrine disturbance affecting young women and is the leading cause of infertility in the United States. Copyright © 2016 F.A. Davis Company
26
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell The etiology of PCOS involves a dysfunctional hypothalamic-pituitary-ovary axis. High serum concentrations of androgenic hormones are present. Multiple cysts develop on the ovary because of multiple areas of follicular cyst formation. Ova develop, come to the surface of the ovary, and form follicular cysts. There is no ovulation. The ovarian surface develops multiple areas of unreleased ova that resemble multiple cysts. Copyright © 2016 F.A. Davis Company
27
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell PCOS may be associated with metabolic syndrome; patients with the disorder should be checked for hypertension, hyperlipidemia, hyperinsulinemia, and glucose intolerance. Copyright © 2016 F.A. Davis Company
28
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Fibrocystic breast disease is the most common disorder of the breast. It presents as benign nodular, granular breast masses that are most prominent during the progesterone-dominant phase of the menstrual cycle. Breast tenderness, vascular engorgement, and cystic distension are the symptoms. Copyright © 2016 F.A. Davis Company
29
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Commonly found in premenopausal women, 25 to 45 years old. Benign tumors Singular, rubbery, round, movable mass There are usually no symptoms, but biopsy or excision is needed to exclude the possibility of cancer. Copyright © 2016 F.A. Davis Company
30
Pathophysiology: Introductory Concepts and Clinical Perspectives by Theresa Capriotti and Joan Parker Frizzell Copyright © 2016 F.A. Davis Company
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.